K-beauty's largest ODM manufacturer posts its highest-ever quarterly sales but fails to convert top-line momentum into earnings growth, as rising production costs and an aggressive capital expansion program compress margins and widen leverage.
Source: Q1 2026 Quarterly Report (13th Fiscal Year, January 1 – March 31, 2026) — Filed May 14, 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions
Cosmax delivered consolidated revenue of ₩682.0 billion in Q1 2026, a 15.9% year-on-year gain that set a new quarterly record for the world's largest cosmetics ODM by sales. Yet the headline growth masked a meaningful deterioration in unit economics: operating profit rose just 3.3% to ₩53.0 billion, and the operating margin contracted 94 basis points from 8.72% to 7.78% as the cost-of-goods-sold ratio climbed from 82.19% to 83.14%. The net income figure of ₩43.8 billion — a 313% surge from the year-ago ₩10.6 billion — demands careful disaggregation, as the prior-year quarter carried ₩49.7 billion in derivative valuation losses and other exceptional financial charges that severely depressed the base; strip those out, and the underlying earnings improvement is far more modest. The quarter is best characterized as an expansion phase: ₩83.5 billion in capital expenditure (2.5× the prior-year pace), ₩143.2 billion in net new borrowings, and a debt-to-equity ratio that widened from 247.1% to 289.6%.
